The Role of Staphylococcus aureus Virulence Factors in Skin Infection and Their Potential as Vaccine Antigens

Pathogens
Keenan A LaceyRachel M McLoughlin

Abstract

Staphylococcus aureus (S. aureus) causes the vast majority of skin and soft tissue infections (SSTIs) in humans. S. aureus has become increasingly resistant to antibiotics and there is an urgent need for new strategies to tackle S. aureus infections. Vaccines offer a potential solution to this epidemic of antimicrobial resistance. However, the development of next generation efficacious anti-S. aureus vaccines necessitates a greater understanding of the protective immune response against S. aureus infection. In particular, it will be important to ascertain if distinct immune mechanisms are required to confer protection at distinct anatomical sites. Recent discoveries have highlighted that interleukin-17-producing T cells play a particularly important role in the immune response to S. aureus skin infection and suggest that vaccine strategies to specifically target these types of T cells may be beneficial in the treatment of S. aureus SSTIs. S. aureus expresses a large number of cell wall-anchored (CWA) proteins, which are covalently attached to the cell wall peptidoglycan. The virulence potential of many CWA proteins has been demonstrated in infection models; however, there is a paucity of information regarding their roles during...Continue Reading

References

Aug 12, 1983·Journal of Immunological Methods·R LindmarkJ Sjöquist
May 11, 2000·Proceedings of the National Academy of Sciences of the United States of America·S K MazmanianO Schneewind
Sep 3, 2002·European Journal of Radiology·Süleyman MenMert Köroğlu
Mar 15, 2003·Science·Capucine PicardJean-Laurent Casanova
Apr 30, 2003·The Journal of Experimental Medicine·Carl S Goodyear, Gregg J Silverman
Mar 25, 2004·Nature Reviews. Immunology·Thomas S Kupper, Robert C Fuhlbrigge
Dec 3, 2005·Nature Reviews. Microbiology·Timothy J Foster
Apr 28, 2006·FEMS Microbiology Letters·Judy HigginsTimothy J Foster
Aug 18, 2006·The New England Journal of Medicine·Gregory J MoranUNKNOWN EMERGEncy ID Net Study Group
Sep 20, 2006·The Journal of Experimental Medicine·Spencer C LiangLynette A Fouser
Nov 1, 2006·Proceedings of the National Academy of Sciences of the United States of America·Yukiko K Stranger-JonesOlaf Schneewind
Sep 21, 2007·The New England Journal of Medicine·Steven M HollandBodo Grimbacher
Jan 18, 2008·PLoS Medicine·Heiman F L WertheimAlex van Belkum
Jan 30, 2008·Infection and Immunity·Simon R Clarke, Simon J Foster
May 16, 2008·Journal of the American Society of Nephrology : JASN·Nicolle Helena Renier LitjensMichiel Gerardus Henricus Betjes
Jul 30, 2008·Archives of Internal Medicine·Adam L HershRalph Gonzales
Aug 2, 2008·Science·Horst von BernuthJean-Laurent Casanova
Jan 10, 2009·Annual Review of Immunology·Thomas KornVijay K Kuchroo
Jan 1, 2008·Advances in Dermatology·Lloyd S Miller
Apr 9, 2009·The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Médicale·Vincent Ki, Coleman Rotstein
Jun 16, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Alice G ChengDominique M Missiakas

❮ Previous
Next ❯

Citations

Sep 23, 2016·Expert Review of Vaccines·Susanna Esposito, Nicola Principi
Jan 31, 2017·Vaccines·Marco Cavallari, Gennaro De Libero
Jan 4, 2017·Pediatric Emergency Care·Loren G Yamamoto
Dec 19, 2016·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Nasim HajighahramaniYounes Ghasemi
Feb 9, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·John M LeechRachel M McLoughlin
Sep 28, 2017·Infection and Immunity·Keenan A LaceyRachel M McLoughlin
May 19, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Joana C MatosM Clara Gonçalves
May 23, 2017·Frontiers in Cellular and Infection Microbiology·Giampiero PietrocolaPietro Speziale
Apr 30, 2019·Surgical Infections·Philip S BarieRobert G Sawyer
Jun 26, 2020·Frontiers in Immunology·Roberto RosiniRino Rappuoli
Sep 27, 2018·BMC Microbiology·Karine Lena MeneghettiGertrudes Corção
Mar 14, 2019·International Journal of Molecular Sciences·Xavier ArgemiGilles Prévost
Mar 27, 2020·Dermatitis : Contact, Atopic, Occupational, Drug·Jonwei HwangVivian Y Shi
Aug 2, 2020·Journal of Applied Microbiology·Z ShakeranR Emamzadeh
Jun 15, 2017·Frontiers in Cellular and Infection Microbiology·Haiyong GuoYinduo Ji
Jul 13, 2018·Therapeutic Advances in Vaccines and Immunotherapy·E David G McIntosh
Jun 2, 2020·Frontiers in Immunology·Nastaran Mues, Hong Wei Chu
Aug 20, 2019·Bioorganic & Medicinal Chemistry·Patrick M WehrliJohan Gottfries
Feb 6, 2021·Frontiers in Immunology·Grace R PidwillSimon J Foster
Oct 5, 2020·The Journal of Allergy and Clinical Immunology·Arwa Al KindiJoanne L Pennock
Mar 12, 2021·Frontiers in Microbiology·Gabrielle S DijksteelBouke K H L Boekema
May 13, 2021·Journal of Biomolecular Structure & Dynamics·Tushar ChakrabortySubrata Sau
Jul 13, 2019·Microbiology Spectrum·Richard A Proctor
Apr 18, 2019·Dermatology : International Journal for Clinical and Investigative Dermatology·Danuta Nowicka, Ewelina Grywalska

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.